(25) used computed tomography (CT) to predict non-small cell lung cancer CD3+ and CD8+ TIL levels and developed a classifier with AUCs of 0.94 and 0.87 in the validation sets, respectively. Here, CD8A is linked to non-small cell lung carcinoma.